Cognitive performance, neuropsychiatric symptoms, and cerebrospinal fluid viral control following programmatic switch from efavirenz-based to dolutegravir-based antiretroviral therapy in South Africa (CONNECT): a prospective cohort study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet HIV

Topics

Medicine

Internal Medicine

Pediatrics

Emergency Medicine

Virology

Show all topics

DOI

10.1016/s2352-3018(24)00209-1